Business Description
Innoviva is a US-based healthcare company that earns royalties from a range of respiratory medicines, including several once-daily inhaled treatments for conditions such as asthma and chronic obstructive pulmonary disease, developed through a long-standing partnership with Glaxo Group. The company also sells a growing portfolio of hospital-focused antibiotics and infection treatments targeting serious conditions like bacterial pneumonia, bloodstream infections, and skin infections. Beyond its current products, Innoviva is researching bacteriophage-based therapies that may one day offer new ways to fight infectious disease. Founded in 1996 and headquartered in Burlingame, California, the company was previously known as Theravance before adopting its current name in 2016.
